Table 2.
Treatment benefits reported by patients in exit interviews following the SURPASS trials (N = 28)
| Treatment benefitsa | Patients reporting each type of treatment benefit n (%) |
|---|---|
| Improved blood glucose/HbA1c | 27 (96%) |
| Weight loss | 26 (93%) |
| Decreased appetite | 22 (79%) |
| Increased energy | 22 (79%) |
| Improved sleep | 8 (29%) |
| Improved blood pressure | 6 (21%) |
| Psychological benefit | 5 (18%) |
| Decreased nocturia | 3 (11%) |
| Improved neuropathy | 3 (11%) |
| Improved eyesight | 2 (7%) |
| Increased ability to focus | 2 (7%) |
aThis column lists all treatment benefits reported by more than one of the 28 patients who participated in the exit interviews